Brief breaks in genetic material may complete intestinal cell maturation and curb harmful growth
Brief activation of caspase-activated DNase (CAD), an enzyme that cuts DNA, may complete intestinal cell maturation after barrier repair and limit pathological descendants. Predominant death of cells with recorded breaks, or retained benefit with CAD switched off, would reject the mechanism.
Stage of verification
- Hypothesis published2026-10-05
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Enzyme
CAD
Caspase-activated DNase, an enzyme that cleaves DNA
Where this hypothesis actsMaturing intestinal epithelial cells after barrier restoration
Hypotheses on this target 1
Inhibition
Activation1
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation
What is proposed
Activation
Briefly activate CAD to promote stable differentiation
With whatNot stated in the record
HowA temporarily inducible CAD activation system producing brief, localized DNA cleavage, followed by precise repair
Possible result
Possible stable differentiation, reduced pathological clonal expansion and lower tumour mortality
From the recordВозможный миметик представляет собой временно включаемую систему активации CAD в созревающих эпителиальных клетках после восстановления барьера.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Repairing the intestine may require a reliable way to stop rebuilding once the work is done. The unexpected move is to propose that briefly cutting and then accurately repairing a cell's genetic material could help secure that stopping point. This is a hypothesis generated by the pipeline, not a measured finding: the proposed benefit depends on the affected cells surviving, remaining mature and producing fewer descendants involved in harmful growth.
- After the intestinal lining restores its barrier, a temporary activation system switches on CAD in cells becoming mature.
- CAD briefly cuts genetic material at localized sites in those cells.
- Accurate repair of the cuts is proposed to secure the switch from a rebuilding state to a stable mature state.
- Surviving mature cells are predicted to return less often to harmful growth and produce fewer abnormal descendants.
- Reduced harmful growth is proposed to lower deaths from tumors and thereby extend life.
The proposal resembles making a small cut in a repaired garment so that a final fastening can be fitted and the opening stays closed.
Where the picture breaks: A garment cannot die or pass an incorrectly repaired cut to its descendants. Cutting genetic material can have those consequences, and the supplied evidence does not establish that the proposed cuts function as a fastening.
- Master questionstep 01 of 04
Interventions that reproduce useful natural bodily processes are sought as possible ways to extend life.
Rests on: The goal is to identify processes worth reproducing, possible ways to reproduce them and reasons they might extend life.
Stated in the chain - Goal pillarstep 02 of 04
A defined set of new interventions would reproduce natural bodily processes with the aim of extending life.
Rests on: The preceding question explicitly requests new candidates and explanations of their possible benefits.
Stated in the chain - Gap questionstep 03 of 04
Timely completion of tissue repair is put forward as potentially better for longevity than stronger repair, if both restore tissue equally early but only timely completion restrains pathological clones, groups of descendants of individual cells that participate in abnormal growth.
Rests on: The preceding goal permits proposals that reproduce natural processes, but does not identify completion of repair as the process to target.
LeapNeither the preceding stages nor the supplied sources establish the proposed contrast: equal early repair followed by uniquely durable restraint of abnormal cell descendants when repair is brought to a timely end.
- Hypothesisstep 04 of 04
Brief, localized cutting of genetic material is proposed to complete differentiation, the acquisition of a cell's mature specialized state, in the intestinal lining. Accurate repair of those cuts would then keep cells out of the rebuilding state, reducing harmful descendants and eventually deaths from tumors.
Rests on: The preceding question supplies the proposed advantage to explain: equal early repair with less subsequent abnormal growth. This hypothesis supplies a candidate mechanism for that advantage and predicts that selectively preventing the cuts would remove it.
Stated in the chain
What is carried, and what is not. None of the four screened sources directly establishes a link in this proposed intestinal sequence; they provide background from other cell systems rather than evidence that cutting, accurate repair and lasting maturation occur in this order. The supplied Cell Death and Differentiation study from 2022 describes damage to genetic material during Helicobacter pylori bacterial infection of stomach-lining cells and suggests that damage below the level that kills cells may contribute to inherited changes in genetic material and cancer; it does not establish either that risk or the proposed benefit for temporary CAD activation during intestinal repair.
Where the reasoning is carried by something unstated · 1
- Gap question. Neither the preceding stages nor the supplied sources establish the proposed contrast: equal early repair followed by uniquely durable restraint of abnormal cell descendants when repair is brought to a timely end. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Fewer abnormal descendants could mean that the intervention killed their parent cells, rather than making surviving cells remain mature. What closes it: The proposed tracking of individual cells must connect recorded cuts to survival, sustained maturation and subsequent descendants in the same cells. A reduction in abnormal descendants alone cannot establish the mechanism.
- Smaller abnormal cell groups during treatment could reflect a temporary slowing of cell division rather than a lasting exit from the rebuilding state. What closes it: Early recovery and the later slowing of cell division must be matched as specified, and cell descendants must be followed after the intervention ends. A criterion for persistent maturation and restraint of growth must be fixed before interpreting the results; the supplied specification provides no follow-up duration.
- An apparent benefit could arise through a rival route, such as reduced inflammatory stimulation from intestinal contents, rather than through accurately repaired CAD cuts. What closes it: The proposed comparison of disabled CAD, restored normal CAD and a version unable to cut genetic material must verify the intended differences in cutting activity. Measurements must also distinguish the rival changes in intestinal contents and inflammation from the claimed sequence of cuts, accurate repair and lasting maturation; smaller abnormal cell groups do not make that distinction.
What would make this wrong. The proposed mechanism would be contradicted if lasting maturation and restraint of abnormal descendants persisted despite verified removal of CAD's cutting activity under the specified matched recovery conditions. It would also fail if the cells with recorded cuts predominantly died rather than surviving and becoming durably mature. A benefit confined to the treatment period would not support the proposed lasting protection, and the further claim about longevity would remain unestablished without lifespan results.
What it would change. If the mechanism held, the search for interventions that extend life would gain a candidate process to reproduce: securing the end of intestinal repair through a controlled episode of cutting and accurate repair of genetic material. Candidate interventions would need to be assessed for durable maturation in surviving cells, alongside their effects on early recovery. Even a successful test in organoids, laboratory-grown three-dimensional tissue models, would not establish lower tumor mortality or longer life in an intact animal or humans; the supplied proposal makes accurate repair without additional lasting changes to genetic material a prerequisite for later lifespan testing.
Sources read · 4
Ebp1 isoforms distinctively regulate cell survival and differentiation. · Proceedings of the National Academy of Sciences of the United States of America · 2006
“Ebp1 binds nuclear Akt and prevents DNA fragmentation by inhibiting caspase-activated DNase.”
Does not settle: Источник не устанавливает, что кратковременное локализованное расщепление ДНК с участием CAD необходимо для окончательной дифференцировки кишечного эпителия, что разрывы затем точно восстанавливаются, что этот процесс закрепляет выход из регенеративной программы или что его миметик ограничивает патологические клоны и снижает опухолевую смертность. Исследование описывает клетки PC12 и изоформы Ebp1; данные о кишечных клетках, восстановлении барьера, подавлении Wnt, SPV_1 и SPV_2 отсутствуют.
MEG3 Regulates CSE-Induced Apoptosis by Regulating miR-421/DFFB Signal Axis. · International journal of chronic obstructive pulmonary disease · 2023
“To study COPD in vitro, in CSE group, we treated HPMECs and HBECs cells with 5% CSE for 24 h.”
Does not settle: Источник не устанавливает роль CAD в созревании кишечного эпителия, восстановлении разрывов ДНК, выходе из регенеративной программы, подавлении патологических клонов, опухолевой смертности или изменении SPV_1 и SPV_2.
DNase I Induces Other Endonucleases in Kidney Tubular Epithelial Cells by Its DNA-Degrading Activity. · International journal of molecular sciences · 2020
“Endonuclease-mediated DNA fragmentation is both an immediate cause and a result of apoptosis and of all other types of irreversible cell death after injury.”
Does not settle: Источник не исследует кишечные клетки, их окончательную дифференцировку, восстановление разрывов ДНК, подавление Wnt, патологические клоны, опухолевую смертность, SPV_1 или SPV_2. Эксперименты проведены на клетках почечных канальцев крысы с избыточной экспрессией DNase I, поэтому они не устанавливают пользу, безопасность, дозу, длительность или механизм временной активации CAD после восстановления кишечного барьера.
Mitochondria supply sub-lethal signals for cytokine secretion and DNA-damage in H. pylori infection. · Cell death and differentiation · 2022
“Further, DNA-damage through sub-lethal mitochondrial signals is likely to contribute to mutagenesis and cancer development.”
Does not settle: The source does not establish effects on intestinal regeneration or terminal differentiation, precise repair of CAD-induced breaks, suppression of pathological clones, tumor mortality, SPV_1, or SPV_2. It studies sub-lethal signaling and DNA damage during H. pylori infection of gastric epithelial cells, including AGS gastric carcinoma cells.
The gap this hypothesis explains
Two established results predict opposite outcomes, and both cannot be right.
Can mimicking timely repair completion extend life more than boosting repair by limiting later growth of abnormal cell groups?
Original wording · exactly as the pipeline generated it
Может ли миметик своевременного завершения регенерации продлевать жизнь сильнее миметика её усиления, если при одинаковом раннем восстановлении только первый ограничивает последующее расширение патологических клонов?
What this question is asking
The question compares two ways of copying the body's tissue-repair processes: strengthening repair and bringing it to a timely end. It asks whether repeated treatments that promote completion could extend remaining life more than treatments that strengthen repair, when both restore the tissue's protective barrier equally well at first. It assumes that only the completion treatment limits the later expansion of pathological clones, meaning groups of cells descended from one cell that have disease-associated properties. It also asks whether tissue aging changes which phase of repair determines the long-term benefit or harm.
- Mimetic
- An intervention intended to reproduce some effect of a natural biological process. Here it refers to copying either stronger tissue repair or its timely completion; no particular substance or intervention is specified.
- Regeneration or tissue repair
- The processes through which damaged tissue recovers. The question distinguishes an early period of recovery from the later ending of repair activity, without establishing precise boundaries between these phases.
- Timely repair completion
- Ending repair activity at a time that preserves its useful recovery effects. The supplied material does not specify how that time is recognized or measured.
- Tissue barrier
- A tissue's protective separation between compartments or between the body and its surroundings. Restoring this function is the proposed early benefit, but the specific tissue and measurement are not identified.
- Pathological clone
- A group of cells descended from a common ancestor cell and described as having disease-associated properties. Clone expansion means that this group grows; the input does not specify which properties make a clone pathological or whether every such clone leads to cancer.
- Remaining lifespan
- The length of life after a specified starting point, such as treatment initiation. It is distinct from early tissue recovery or the amount of abnormal cell growth.
- Tissue aging
- Changes in tissue as it grows older. The question asks whether these changes alter the treatment comparison, but supplies no age categories or measure of tissue aging.
- Signaling pathway
- A connected sequence of cellular signals that influences what cells do. S4 distinguishes which repair-related pathway is active from how long that activity continues.
- Stem cell
- A cell capable of maintaining a cell supply and producing cells that contribute to tissue renewal. S2's model concerns the subset activated in association with repair, rather than all stem cells.
- Time-weighted measure
- A measure that accounts for how long different values persist. In S2, the prediction concerns activated cell numbers over time rather than a single cell count.
- Inflammation and its resolution
- Inflammation is a biological response to injury or harmful stimuli; resolution is the process by which that response ends. S3 hypothesizes impaired resolution, which is related to, but does not establish, the proposed comparison of repair treatments.
- Mutation
- A change in a cell's genetic material. S3 hypothesizes a type of mutation that interferes with the ending of inflammation.
- Cancer-promoting or carcinogenic
- Contributing to the development of cancer. S4 uses this outcome to distinguish potentially harmful prolonged repair signaling from safe regeneration; it does not measure the lifespan effects of the proposed treatments.
- Acute and chronic injury
- Acute injury occurs over a relatively short period, while chronic injury persists or recurs. These are the injury contexts identified for S4, rather than specified treatment schedules.
At equal early recovery, only a mimetic of timely regeneration completion limits subsequent expansion of pathological clones.
A mimetic is a treatment intended to reproduce a natural process; here, the two processes are strengthening tissue repair and ending it at the appropriate time. The assumption is that both treatments initially restore tissue function equally well, but only the completion treatment restrains later growth of disease-associated cell families. If established, this would make later cell growth a possible explanation for a difference in remaining lifespan.
S4 supports a narrower timing-related proposition: in its discussion of liver cancer, it states that the duration of repair-related signaling determines whether regeneration remains safe or becomes cancer-promoting. It does not establish equal early recovery under two mimetics, or that only a completion mimetic limits pathological clones. S2 supplies a theoretical connection between sustained activation of repair-associated stem cells and cancer risk, rather than evidence for this treatment comparison. The supplied sources therefore support part of the rationale, but not the asserted comparative result.S4S2
The same question asked without the part nothing read establishes:
- When two treatments restore a tissue barrier equally well at first, does mimicking timely repair completion extend remaining life more than strengthening repair?
- How do treatments that promote repair completion versus stronger repair differ in later abnormal cell expansion and remaining lifespan?
- Does tissue aging change the long-term effects of strengthening repair compared with promoting its timely completion?
- Timely completion extends life more Under the question's assumptions, both treatments would deliver the same early recovery, while the completion treatment would leave less subsequent abnormal cell expansion. A longer remaining lifespan would be consistent with that later difference outweighing any benefit of continued repair, although the lifespan difference alone would not prove its cause.
- Both extend life equally Even if the completion treatment limited abnormal cell expansion more effectively, that difference would not produce a greater lifespan benefit over the period measured. Early repair, later cell growth and remaining lifespan would therefore be distinct outcomes rather than interchangeable measures of success.
- Stronger repair extends life more Under the same assumed early recovery and clone-growth difference, stronger repair would nevertheless produce the better survival outcome. This would mean that restricting abnormal cell expansion was insufficient to determine the overall lifespan effect; the supplied sources do not establish what would account for that result.
- The ranking changes with tissue age The same early recovery and later difference in abnormal cell growth could accompany different lifespan rankings in younger and older tissue. A result established at one tissue age would then fail to settle the comparison at another; the supplied sources do not establish whether such a reversal occurs.
The proposed benefit begins with restoring a damaged tissue barrier, allowing the tissue to perform its protective role again. The question then separates that early recovery from what happens to abnormal cell groups afterward. If equally effective early repair is followed by different amounts of harmful cell expansion, early recovery alone would not establish which treatment has the better long-term outcome. However, even less abnormal cell expansion would not by itself establish longer life; that final connection remains unmeasured in the supplied evidence.
S-узлы уровня RL-1 поддерживают усиление регенерации, её последующее торможение и возможность клонального отбора; общий долгосрочный исход неизвестен.
Повторные циклы миметика восстанавливают барьер и увеличивают оставшуюся жизнь при отсутствии ускоренного расширения патологических клонов.
Не установлено, какая фаза определяет знак долгосрочного эффекта при одинаковой ранней пользе и меняется ли это со старением ткани.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Миметик завершения регенерации может ограничивать патологические клоны посредством краткого, локализованного расщепления ДНК каспаза-активируемой ДНКазой CAD. Гипотеза утверждает, что такой физиологический этап необходим для окончательной дифференцировки восстановившихся кишечных клеток: последующее точное восстановление разрывов закрепляет выход из регенеративной программы. Возможный миметик представляет собой временно включаемую систему активации CAD в созревающих эпителиальных клетках после восстановления барьера. Его предполагаемая польза проходит через уменьшение повторного вовлечения этих клеток в патологический рост и далее через снижение опухолевой смертности. Радикальное утверждение состоит в том, что избирательное предотвращение этого короткого эпизода повреждения ДНК ухудшит долгосрочный результат даже при сохранении раннего восстановления и подавления Wnt. Основная стабилизируемая характеристика — SPV_1; увеличение SPV_2 остаётся проверяемым следствием.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковом раннем восстановлении и одинаковом позднем снижении пролиферации выключение каталитической активности CAD устранит устойчивую дифференцировку и последующее ограничение патологических линий. Возвращение кратковременной активности нормального CAD восстановит оба эффекта; каталитически неактивный вариант окажется бесполезен. Решающее наблюдение: клетки с зарегистрированными кратковременными разрывами останутся живыми, завершат дифференцировку и дадут меньше патологических потомков. Если они преимущественно погибают либо польза сохраняется при выключенном CAD, предложенный механизм опровергнут.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable loss and restoration of effects, cell survival and differentiation, reduced pathological progeny, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Индуцируемая экспрессия, каталитические мутанты, картирование разрывов и прослеживание отдельных клеток позволяют проверить механизм в органоидах. Готового селективного лекарственного миметика для этого назначения нет. Проверка продолжительности жизни допустима как следующий экспериментальный этап после установления точности репарации и отсутствия дополнительного мутагенеза.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковом раннем восстановлении и одинаковом позднем снижении пролиферации выключение каталитической активности CAD устранит устойчивую дифференцировку и последующее ограничение патологических линий. Возвращение кратковременной активности нормального CAD восстановит оба эффекта; каталитически неактивный вариант окажется бесполезен. Решающее наблюдение: клетки с зарегистрированными кратковременными разрывами останутся живыми, завершат дифференцировку и дадут меньше патологических потомков. Если они преимущественно погибают либо польза сохраняется при выключенном CAD, предложенный механизм опровергнут.
- Rival 01 of 04What would separate them
Timely regeneration completion may limit harmful clones by reducing mobile DNA insertions predicts: При равном суммарном числе делений позднее подавление LINE-1 уменьшит число новых подтверждённых вставок и патологическое расширение линий, сохранив раннее восстановление. Оно также устранит дополнительное преимущество миметика завершения, если оба действуют через один механизм. Напротив, сохранение преимущества завершения при практически устранённой ретротранспозиции опровергнет её определяющую роль. Перестановка последовательности циклов при одинаковом наборе нагрузок отдельно проверит предсказание модели накопления.
- Rival 02 of 04What would separate them
Restoring intestinal alkaline phosphatase may limit pathological growth after regeneration predicts: При одинаковой проницаемости эпителия, одинаковом содержании кислорода и одинаковом количестве бактерий активный фермент уменьшит воспалительную активность кишечного содержимого и позднее расширение патологических линий; каталитически неактивный фермент этого не сделает. Подавление эндогенной кишечной щелочной фосфатазы устранит преимущество завершения, а добавление активного фермента восстановит его. Сохранение преимущества при отсутствии измеримого дефосфорилирования опровергнет гипотезу.
- Rival 03 of 04What would separate them
Restoring oxygen consumption in colon cells may limit pathological clones after regeneration predicts: При одинаковом раннем восстановлении и сохранённой активности кишечной щелочной фосфатазы преимущество позднего миметика исчезнет при избирательном подавлении окислительного обмена колоноцитов. Независимое восстановление низкой доступности кислорода вернёт защиту. В определённом микробном сообществе замена бактерий на сопоставимые варианты, лишённые соответствующего преимущества дыхания, должна резко уменьшить различие между усилением и завершением регенерации. Если защита сохраняется при экспериментально фиксированных кислороде и бактериальном дыхании, гипотеза опровергнута.
- What would separate them
A late aryl hydrocarbon receptor signal may pause clone growth without extending life predicts: После полного прекращения воздействия патологические линии из обеих групп покажут сопоставимую способность к повторному росту в общей среде и сопоставимую опухолеобразующую способность. При продолжительном наблюдении до конца жизни различие в размерах клонов не перейдёт в преимущество общей выживаемости. Устойчивое уменьшение опухолевого потенциала после отмены вместе с увеличением оставшейся жизни опровергнет эту гипотезу в пользу одного из механизмов полноценного завершения.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
В мышечных клетках подавление CAD уменьшало образование разрывов и блокировало дифференцировку, включая нормальную активацию p21. Это экспериментальный пример связи программируемого повреждения с созреванием клетки, но ещё не подтверждение кишечного механизма. [Исследование каспазы-3 и CAD](https://pubmed.ncbi.nlm.nih.gov/20160104/).
Геронтология регенерации и профилактика опухолей. Потребовал бы пересмотра учебного раздела «Геномная нестабильность и противоопухолевая защита»: для конкретной фазы миметика предотвращение программируемых разрывов ДНК могло бы ухудшать защиту от патологического роста.
Миметик с большим кратковременным числом программируемых разрывов ДНК обеспечит меньшую позднюю опухолевую нагрузку и большую оставшуюся продолжительность жизни, чем вариант, избирательно предотвращающий эти разрывы.
Известна роль CAD в дифференцировке, поэтому сама идея полезных разрывов ДНК не является новой. В выполненном целевом поиске не найдено обоснования более сильного утверждения: обязательная CAD-зависимая фаза кишечного миметика увеличивает продолжительность жизни, а её избирательное предотвращение сокращает её. Это ограниченная проверка новизны, а не доказательство отсутствия такой позиции во всей литературе; строгий тест HERETICAL остаётся предварительным.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.